Roivant Sciences (ROIV) EBIT Margin (2020 - 2025)
Historic EBIT Margin for Roivant Sciences (ROIV) over the last 6 years, with Q4 2025 value amounting to 16966.13%.
- Roivant Sciences' EBIT Margin fell 139235400.0% to 16966.13% in Q4 2025 from the same period last year, while for Dec 2025 it was 20987.61%, marking a year-over-year decrease of 415114000.0%. This contributed to the annual value of 3453.32% for FY2025, which is 172002500.0% down from last year.
- Per Roivant Sciences' latest filing, its EBIT Margin stood at 16966.13% for Q4 2025, which was down 139235400.0% from 19492.87% recorded in Q3 2025.
- Over the past 5 years, Roivant Sciences' EBIT Margin peaked at 32948.56% during Q4 2023, and registered a low of 19492.87% during Q3 2025.
- Moreover, its 5-year median value for EBIT Margin was 3042.59% (2024), whereas its average is 3642.27%.
- As far as peak fluctuations go, Roivant Sciences' EBIT Margin surged by 351657600bps in 2023, and later tumbled by -359911500bps in 2024.
- Roivant Sciences' EBIT Margin (Quarter) stood at 1010.73% in 2021, then tumbled by -119bps to 2217.2% in 2022, then soared by 1586bps to 32948.56% in 2023, then crashed by -109bps to 3042.59% in 2024, then crashed by -458bps to 16966.13% in 2025.
- Its EBIT Margin stands at 16966.13% for Q4 2025, versus 19492.87% for Q3 2025 and 13130.05% for Q2 2025.